Phosphospecificity: Whole cell extracts of control (co), EGF stimulated (EGF) or pervanadate treated (VH) A549 tumor cells were applied to SDS-PAGE (ca 20.000 cells per lane) and transferred to a PVDF membrane. The immunoblot was probed with mab MEK1/2-7E10 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec).
Phosphospecificity: Whole cell extracts of control (co), EGF stimulated (EGF) or pervanadate treated (VH) A549 tumor cells were applied to SDS-PAGE (ca 20.000 cells per lane) and transferred to a PVDF membrane. The immunoblot was probed with mab MEK1/2-7E10 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec).
MEK1 (MAP2K1) (incl. pos. control) Mouse Monoclonal Antibody [Clone ID: 7E10]
AM00090PU-N
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityCanine, Human, Mouse
TargetMAP2K1
Overview
- SupplierOriGene
- Product NameMEK1 (MAP2K1) (incl. pos. control) Mouse Monoclonal Antibody [Clone ID: 7E10]
- Delivery Days Customer14
- ApplicationsWestern Blot, ELISA
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7E10
- Gene ID5604
- Target nameMAP2K1
- Target descriptionmitogen-activated protein kinase kinase 1
- Target synonymsCFC3; dual specificity mitogen-activated protein kinase kinase 1; ERK activator kinase 1; MAPK/ERK kinase 1; MAPKK 1; MAPKK1; MEK 1; MEK1; MEL; MKK1; PRKMK1; protein kinase, mitogen-activated, kinase 1 (MAP kinase kinase 1)
- HostMouse
- IsotypeIgG1
- Scientific DescriptionMEK1 (MAP2K1) (incl. pos. control) mouse monoclonal antibody, clone 7E10, Purified
- ReactivityCanine, Human, Mouse
- UNSPSC12352203